04/17/2025
4:17 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
04/08/2025
5:10 AM | OncoCyte (Filer)
| Form 424B3 | |
03/31/2025
12:25 PM | OncoCyte (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/24/2025
3:10 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:16 PM | OncoCyte (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
6:06 PM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13G/A | |
02/24/2025
5:03 AM | OncoCyte (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2025
1:41 PM | AWM Investment Company, Inc. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
6:00 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
7:46 PM | BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for OCX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. |
02/10/2025
7:43 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
8:03 AM | OncoCyte (Filer)
| Form 424B5 | |
02/10/2025
8:17 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
4:00 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:05 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
8:58 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SCHEDULE 13G/A | |
12/27/2024
8:42 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2024
8:49 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
5:17 PM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:30 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SC 13G/A | |
12/09/2024
7:00 AM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
11:13 AM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SC 13G/A | |
10/22/2024
3:12 PM | OncoCyte (Filer)
| Form 424B3 | |
10/21/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
10/18/2024
3:55 PM | OncoCyte (Filer)
| Form S-3/A | |
10/16/2024
4:16 PM | OncoCyte (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
3:15 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:03 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SC 13G | |
10/04/2024
6:40 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
6:00 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:05 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:09 PM | OncoCyte (Filer)
| Form DEF 14A | |
08/09/2024
5:25 AM | OncoCyte (Filer)
| Form 424B5 | |
08/09/2024
5:37 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
08/08/2024
3:27 PM | OncoCyte (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/05/2024
3:01 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:00 PM | OncoCyte (Issuer)
SILVERMAN LOU (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s tariffs just split the AI market in two (Ad) Trump’s tariff just split the AI market – among others – in two.
One group of AI companies—the ones relying on cheap foreign hardware—just saw their costs shoot through the roof.
For the other group of AI companies, they were just handed a massive competitive advantage.
Make no mistake, AI as a whole is still a game-changer for the global economy.
But within the AI sector, Trump’s tariffs have created a huge divergence. There are those AI companies that will rise to the top… And those that will sink to the bottom. |
07/03/2024
8:00 PM | Last Andrew J. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:00 PM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:47 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:49 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
10:26 AM | OncoCyte (Filer)
| Form 424B3 | |
05/22/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
05/17/2024
4:11 PM | OncoCyte (Filer)
| Form S-3/A | |
05/15/2024
3:21 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:31 PM | OncoCyte (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/29/2024
4:23 PM | OncoCyte (Filer)
| Form DEF 14A | |
